News

Effective Antibody from a Patient recovering from Middle East Respirat


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Effective Antibody from a Patient recovering from Middle East Respiratory Syndrome
 

Date: 29/07/2015


2 month after the outbreak of the coronavirus in South Korea, researchers are presenting first results of an effective treatment for against the Middel East Respiratory Syndrom (MERS). The Swiss biotech Humabs BioMed has been able to isolate an effective antibody from a cured patient that should now be further developed under a non-profit base.

In 2012, a new coronavirus with the origin in the Arabian Peninsula was identified: MERS-CoV. To infect humans, the virus is believed to take a long way, making stopovers in bats and Arabian camels. However, when the virus is transferred from the camels to humans, it can cause a severe illness called Middel East respiratory syndrom (MERS). The disease affects the lungs and the kidneys and is potentially lethal. Current treatments ease the symptoms, but there is no cure for the disease.

For more click here

Source: Labiotech

© Catalyst Innovation Portal 2019